Is IFF profitable in 2026?

Yes. IFF guided FY2026 revenue of $10.5 to $10.8 billion with adjusted EBITDA of $2.05 to $2.15 billion (3 to 8 percent growth), and beat Q1 2026 estimates with $2.74 billion revenue and $1.25 EPS versus $1.08 consensus, as reported February 11 and July 15, 2026.

Could AI replace IFF's perfumers and flavorists?

Not currently. IFF's own SVP of Scent Digital says olfaction data remains far sparser than other senses, so proprietary formulation libraries and regulatory dossiers stay defensible. IFF deploys an internal tool called Jennie to speed up, not replace, human perfumers, per beautymatter.com, May 21, 2026.

Is IFF facing layoffs in 2026?

Headcount fell from about 24,600 in 2023 to about 21,500 in 2024-2025 amid divestitures, and the pending sale of Food Ingredients to CVC plus the July 20, 2026 SuanNutra deal (transferring roughly 600 employees) will reduce headcount further.

Who is IFF's biggest competitor?

IFF competes in a global oligopoly with Givaudan, DSM-Firmenich and Symrise, the so-called big four flavor and fragrance houses, which together hold roughly 51 to 63 percent of relevant sub-markets depending on segment, per gminsights.com data from November 30, 2025.

Is IFF under criminal investigation?

Yes, a DOJ criminal antitrust probe into IFF and three other global fragrance companies is ongoing alongside EU Commission and Swiss COMCO investigations, following IFF's $11 million end-user settlement (fairness hearing September 15, 2026) and a prior $26 million 2025 settlement, per basenotes.com, July 17, 2026.

Is IFF being broken up?

IFF is mid-restructuring: it sold Pharma Solutions to Roquette (May 1, 2025), agreed to sell 90% of Food Ingredients to CVC Capital Partners for about $3.8 billion (closing expected Q2 2027), and sold botanical extracts and vitamins to SuanNutra on July 20, 2026, refocusing on Taste, Scent and Health & Biosciences.

Manufacturing companies · United States

International Flavors & Fragrances

iff.com ↗

Global maker of flavors, fragrances, and scent/taste ingredients for consumer products.

Defensible for now

Assessed 20 July 2026 · Evidence as of 20 July 2026

Real protection, with named pressure against it.

On the recordSince 20 July 2026 · Checkable from September 15, 2026 · Every call on the record Checkpoint: Antitrust class-action fairness hearing over fragrance price-fixing claims

The call

IFF holds its formulation relationships and scale while cutting headcount, selling divisions, and facing a DOJ antitrust probe alongside slow-moving AI scent competitors.

International Flavors & Fragrances (IFF) makes the scents in perfumes and the flavors in food and drinks. It is one of only four companies that control about half the world market, which is hard to break into because IFF has years of recipe data, government approval to sell its products, and long-term contracts with big food companies like Nestlé and Coca-Cola that would be expensive to switch away from. AI startups like Osmo and Patina can now help create new scents faster using computers, but they have not yet convinced IFF's major customers to abandon their existing relationships. The one thing that could change everything is if one of these AI startups convinces a big food company to use them instead, or if the U.S. Justice Department's criminal antitrust investigation against IFF results in serious punishment beyond just fines.

Why

AI pressure: Osmo, Patina, and Institute of Science Tokyo's OGDiffusion (AI-native scent platforms). These labs use AI to design new scent molecules faster, but none has yet taken a formulation program from IFF's CPG clients. Could AI do the core job? Only partly.

Bigger players: Givaudan, Symrise, dsm-firmenich (the other big-four flavor and fragrance makers). Rivals compete for the same accounts, but IFF's embedded customer relationships have not shifted to any of them. Could a giant copy it? No, they are blocked.

What protects it. Decades-long formulation contracts with major CPG brands, proprietary scent data, and regulatory approvals new entrants lack.

What would change this call

Osmo, Patina, or OGDiffusion announces a signed formulation contract with Unilever, P&G, or L'Oreal. Would show AI-native rivals can capture embedded CPG relationships, not just propose molecules.
DOJ antitrust probe results in criminal indictment of IFF or named executives. Would mark escalation from civil fines to material reputational and financial damage.
CVC Capital Partners Food Ingredients deal ($3.8B) closes or collapses before Q2 2027 deadline. Would show whether IFF's restructuring and $1B refinancing plan is on track or stalling.

Key numbers

FY2025 net sales $10.89B, down 5% reported (2025-12-31)
Selling Food Ingredients unit to CVC for ~$3.8B (2026-05-31)
Net debt to EBITDA at 2.5x in Q1 2026 (2026-03-31)

Named risks

DOJ criminal antitrust probe could yield indictment naming individuals and IFF. Severity: high
CVC Food Ingredients deal (Q2 2027 close) tied to $1B refinancing could slip. Severity: medium
AI-native platforms (Osmo, Patina) could land marquee CPG accounts away from IFF. Severity: medium
Continued headcount reduction from 24,600 (2023) to 21,500 (2024-2025) amid restructuring fatigue. Severity: medium
Macro headwinds: Middle East conflict, energy/logistics inflation pressuring H1 2026 margins. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Givaudan	contesting	Both hold roughly 10.5-22% share estimates within a big-four oligopoly, per gitnux.org and fragrantica.com, 2026
DSM-Firmenich	contesting	Formed via 2023 merger, competes as one of big four alongside IFF in taste and scent
Symrise	contesting	~EUR5.0B 2024 sales, part of the big-four oligopoly holding 51-63% combined market share
Osmo	gaining on	Launched commercial AI olfactory platform 'Generation by Osmo' in 2025, accelerating formulation search
Patina	gaining on	Unveiled 'Sense1' molecular-olfaction model at World Perfumery Congress, June 2026

Questions people ask

Is IFF profitable in 2026?: Yes. IFF guided FY2026 revenue of $10.5 to $10.8 billion with adjusted EBITDA of $2.05 to $2.15 billion (3 to 8 percent growth), and beat Q1 2026 estimates with $2.74 billion revenue and $1.25 EPS versus $1.08 consensus, as reported February 11 and July 15, 2026.
Could AI replace IFF's perfumers and flavorists?: Not currently. IFF's own SVP of Scent Digital says olfaction data remains far sparser than other senses, so proprietary formulation libraries and regulatory dossiers stay defensible. IFF deploys an internal tool called Jennie to speed up, not replace, human perfumers, per beautymatter.com, May 21, 2026.
Is IFF facing layoffs in 2026?: Headcount fell from about 24,600 in 2023 to about 21,500 in 2024-2025 amid divestitures, and the pending sale of Food Ingredients to CVC plus the July 20, 2026 SuanNutra deal (transferring roughly 600 employees) will reduce headcount further.
Who is IFF's biggest competitor?: IFF competes in a global oligopoly with Givaudan, DSM-Firmenich and Symrise, the so-called big four flavor and fragrance houses, which together hold roughly 51 to 63 percent of relevant sub-markets depending on segment, per gminsights.com data from November 30, 2025.
Is IFF under criminal investigation?: Yes, a DOJ criminal antitrust probe into IFF and three other global fragrance companies is ongoing alongside EU Commission and Swiss COMCO investigations, following IFF's $11 million end-user settlement (fairness hearing September 15, 2026) and a prior $26 million 2025 settlement, per basenotes.com, July 17, 2026.
Is IFF being broken up?: IFF is mid-restructuring: it sold Pharma Solutions to Roquette (May 1, 2025), agreed to sell 90% of Food Ingredients to CVC Capital Partners for about $3.8 billion (closing expected Q2 2027), and sold botanical extracts and vitamins to SuanNutra on July 20, 2026, refocusing on Taste, Scent and Health & Biosciences.

Timeline

2026-07-20IFF agrees to sell botanical extracts, vitamins and food enhancement unit (~$170M revenue, ~600 staff) to SuanNutra
2026-05-05IFF stock surges 17.2% after Q1 2026 earnings beat ($2.74B revenue, $1.25 EPS)
2026-05IFF agrees to sell 90% of Food Ingredients business to CVC Capital Partners for ~$3.8B, closing Q2 2027
2026-02-11IFF reports FY2025 net sales of $10.89B, down 5% reported, and issues FY2026 guidance
2025-05-01IFF completes divestiture of Pharma Solutions business to Roquette
2024-12-31EU Commission fines IFF EUR15.9M for deleting WhatsApp messages during antitrust inspection

Revision history

20 July 2026

First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.

In the same band

Boeing Vodafone Group LG Electronics